Europe bets big on biotech

Biotech holds unique potential to address today’s most pressing challenges: helping us adapt to climate change, secure future-proof food systems, improve health, and strengthen Europe’s strategic autonomy. Without biotech, the pressure on our healthcare, food supply, and environment will only increase, and we risk falling behind in a rapidly changing world. That’s why it is good to see – and without surprise – that in its 2025 Strategic Foresight Report, the European Commission has identified biotech as one of the breakthrough technologies set to shape Europe’s next decades, alongside quantum, neurotechnology, and advanced materials. And luckily, this isn’t just a signal: it also comes with serious backing. The Commission has also confirmed it will mobilize €450 billion between 2025 and 2034 to strategic sectors like biotech, health, agriculture, and the bioeconomy. This long-term European Competitiveness Fund will offer a mix of grants, equity, and guarantees to support startups and scale-ups, aiming to boost European innovation, resilience, and industrial leadership, and to create a healthier, climate-friendly and more independent future for Europe.